1. Home
  2. CVRX vs SENS Comparison

CVRX vs SENS Comparison

Compare CVRX & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CVRx Inc.

CVRX

CVRx Inc.

HOLD

Current Price

$7.31

Market Cap

201.0M

Sector

Health Care

ML Signal

HOLD

Logo Senseonics Holdings Inc.

SENS

Senseonics Holdings Inc.

HOLD

Current Price

$7.15

Market Cap

225.5M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CVRX
SENS
Founded
2000
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
201.0M
225.5M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
CVRX
SENS
Price
$7.31
$7.15
Analyst Decision
Buy
Strong Buy
Analyst Count
6
6
Target Price
$13.17
$25.58
AVG Volume (30 Days)
371.4K
449.6K
Earning Date
02-04-2026
03-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$55,969,000.00
$29,298,000.00
Revenue This Year
$11.91
$59.55
Revenue Next Year
$15.28
$70.49
P/E Ratio
N/A
N/A
Revenue Growth
18.44
31.94
52 Week Low
$4.30
$5.25
52 Week High
$17.78
$28.00

Technical Indicators

Market Signals
Indicator
CVRX
SENS
Relative Strength Index (RSI) 50.09 54.79
Support Level $6.96 $6.98
Resistance Level $6.09 $7.74
Average True Range (ATR) 0.81 0.48
MACD 0.17 -0.01
Stochastic Oscillator 60.17 35.90

Price Performance

Historical Comparison
CVRX
SENS

About CVRX CVRx Inc.

CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.

About SENS Senseonics Holdings Inc.

Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.

Share on Social Networks: